Document is current
Any future updates will be listed below
-
Authors
Pimenta Silva, Daniela
Bouça-Machado, Raquel
Pona-Ferreira, Filipa
Lobo, Teresa
Cacho, Ricardo
Anker, Rebekka
Krakauer, John W.
Ferreira, Joaquim J.
- License Information
-
More Information
Article History
Received: 25 July 2024
Accepted: 29 April 2025
First Online: 11 June 2025
Declarations
:
: This study was approved by the CNS Ethics Committee (Ref. 03-2020) and performed in accordance with national legislation and the Declaration of Helsinki. Individuals who agreed to participate were asked to provide written informed consent.
: All participants consented to these data being published.
: The authors declare no competing interests.DPS was granted by Santa Casa da Misericórdia de Lisboa (“Prémio João Lobo Antunes”) for a project unrelated to the present manuscript. RA was an employee and shareholder of MindMaze SA. JWK has consulted for and has options in MindMaze, Emerja, and Meta. JJF has provided consultancy for AbbVie, BIAL, Biogen, Lundbeck, and Sunovion, has received grants from Angelini, Novartis, Medtronic, AbbVie, Zambon, BIAL, Biogen, and Grunenthal, and has received speaker fees for BIAL, Ono, SK Chemical, Abbvie and Infucure. All other authors have no financial disclosures.
